{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:08:03Z","timestamp":1793941683842,"version":"4.8.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Huntington\u2019s Disease Society of America, Human Biology Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40478-019-0764-9","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T23:04:24Z","timestamp":1564441464000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington\u2019s disease patients"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2615-1213","authenticated-orcid":false,"given":"Peng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Mahesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Paul G.","family":"Vonsattel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley J.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Gomez-Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen H.","family":"Ashe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,30]]},"reference":[{"key":"764_CR1","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.nbd.2004.04.001","volume":"16","author":"CT Aiken","year":"2004","unstructured":"Aiken CT, Tobin AJ, Schweitzer ES (2004) A cell-based screen for drugs to treat Huntington's disease. Neurobiol Dis 16:546\u2013555. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2004.04.001","journal-title":"Neurobiol Dis"},{"key":"764_CR2","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ng0893-398","volume":"4","author":"SE Andrew","year":"1993","unstructured":"Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S, Starr E, Squitieri F, Lin B, Kalchman MA et al (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet 4:398\u2013403. \n                    https:\/\/doi.org\/10.1038\/ng0893-398","journal-title":"Nat Genet"},{"key":"764_CR3","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/sj.cdd.4401492","volume":"11","author":"BC Baliga","year":"2004","unstructured":"Baliga BC, Read SH, Kumar S (2004) The biochemical mechanism of caspase-2 activation. Cell Death Differ 11:1234\u20131241. \n                    https:\/\/doi.org\/10.1038\/sj.cdd.4401492","journal-title":"Cell Death Differ"},{"key":"764_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/brain\/97.1.457","volume":"97","author":"ED Bird","year":"1974","unstructured":"Bird ED, Iversen LL (1974) Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain 97:457\u2013472","journal-title":"Brain"},{"key":"764_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/archneur.1962.04210040027003","volume":"7","author":"JB Bittenbender","year":"1962","unstructured":"Bittenbender JB, Quadfasel FA (1962) Rigid and akinetic forms of Huntington's chorea. Arch Neurol 7:275\u2013288","journal-title":"Arch Neurol"},{"key":"764_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/hmg\/ddu421","volume":"24","author":"D Blum","year":"2015","unstructured":"Blum D, Herrera F, Francelle L, Mendes T, Basquin M, Obriot H, Demeyer D, Sergeant N, Gerhardt E, Brouillet E et al (2015) Mutant huntingtin alters tau phosphorylation and subcellular distribution. Hum Mol Genet 24:76\u201385. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddu421","journal-title":"Hum Mol Genet"},{"key":"764_CR7","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/mds.22204","volume":"24","author":"D Caparros-Lefebvre","year":"2009","unstructured":"Caparros-Lefebvre D, Kerdraon O, Devos D, Dhaenens CM, Blum D, Maurage CA, Delacourte A, Sablonniere B (2009) Association of corticobasal degeneration and Huntington's disease: can tau aggregates protect huntingtin toxicity? Mov Disord 24:1089\u20131090. \n                    https:\/\/doi.org\/10.1002\/mds.22204","journal-title":"Mov Disord"},{"key":"764_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1750-1326-6-59","volume":"6","author":"JB Carroll","year":"2011","unstructured":"Carroll JB, Southwell AL, Graham RK, Lerch JP, Ehrnhoefer DE, Cao LP, Zhang WN, Deng Y, Bissada N, Henkelman RM et al (2011) Mice lacking caspase-2 are protected from behavioral changes, but not pathology, in the YAC128 model of Huntington disease. Mol Neurodegener 6:59. \n                    https:\/\/doi.org\/10.1186\/1750-1326-6-59","journal-title":"Mol Neurodegener"},{"key":"764_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3233\/JHD-140111","volume":"3","author":"MY Davis","year":"2014","unstructured":"Davis MY, Keene CD, Jayadev S, Bird T (2014) The co-occurrence of Alzheimer's disease and Huntington's disease: a neuropathological study of 15 elderly Huntington's disease subjects. J Huntingtons Dis 3:209\u2013217. \n                    https:\/\/doi.org\/10.3233\/JHD-140111","journal-title":"J Huntingtons Dis"},{"key":"764_CR10","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990\u20131993","journal-title":"Science"},{"key":"764_CR11","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nm.3617","volume":"20","author":"M Fernandez-Nogales","year":"2014","unstructured":"Fernandez-Nogales M, Cabrera JR, Santos-Galindo M, Hoozemans JJ, Ferrer I, Rozemuller AJ, Hernandez F, Avila J, Lucas JJ (2014) Huntington's disease is a four-repeat tauopathy with tau nuclear rods. Nat Med 20:881\u2013885. \n                    https:\/\/doi.org\/10.1038\/nm.3617","journal-title":"Nat Med"},{"key":"764_CR12","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","volume":"125","author":"RK Graham","year":"2006","unstructured":"Graham RK, Deng Y, Slow EJ, Haigh B, Bissada N, Lu G, Pearson J, Shehadeh J, Bertram L, Murphy Z et al (2006) Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 125:1179\u20131191. \n                    https:\/\/doi.org\/10.1016\/j.cell.2006.04.026","journal-title":"Cell"},{"key":"764_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/hmg\/ddu456","volume":"24","author":"M Gratuze","year":"2015","unstructured":"Gratuze M, Noel A, Julien C, Cisbani G, Milot-Rousseau P, Morin F, Dickler M, Goupil C, Bezeau F, Poitras I et al (2015) Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease. Hum Mol Genet 24:86\u201399. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddu456","journal-title":"Hum Mol Genet"},{"key":"764_CR14","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","volume":"19","author":"CA Gutekunst","year":"1999","unstructured":"Gutekunst CA, Li SH, Yi H, Mulroy JS, Kuemmerle S, Jones R, Rye D, Ferrante RJ, Hersch SM, Li XJ (1999) Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J Neurosci 19:2522\u20132534","journal-title":"J Neurosci"},{"key":"764_CR15","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"HDCRG","year":"1993","unstructured":"HDCRG (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"764_CR16","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/sj.cdd.4401358","volume":"11","author":"E Hermel","year":"2004","unstructured":"Hermel E, Gafni J, Propp SS, Leavitt BR, Wellington CL, Young JE, Hackam AS, Logvinova AV, Peel AL, Chen SF et al (2004) Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Cell Death Differ 11:424\u2013438. \n                    https:\/\/doi.org\/10.1038\/sj.cdd.4401358","journal-title":"Cell Death Differ"},{"key":"764_CR17","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s007020050095","volume":"105","author":"KA Jellinger","year":"1998","unstructured":"Jellinger KA (1998) Alzheimer-type lesions in Huntington's disease. J Neural Transm (Vienna) 105:787\u2013799. \n                    https:\/\/doi.org\/10.1007\/s007020050095","journal-title":"J Neural Transm (Vienna)"},{"issue":"7","key":"764_CR18","doi-asserted-by":"publisher","first-page":"a024240","DOI":"10.1101\/cshperspect.a024240","volume":"7","author":"Maria Jimenez-Sanchez","year":"2016","unstructured":"Jimenez-Sanchez M, Licitra F, Underwood BR, Rubinsztein DC (2017) Huntington's disease: mechanisms of pathogenesis and therapeutic strategies. Cold Spring Harb Perspect Med 7. \n                    https:\/\/doi.org\/10.1101\/cshperspect.a024240","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"764_CR19","doi-asserted-by":"publisher","first-page":"12784","DOI":"10.1073\/pnas.221451398","volume":"98","author":"YJ Kim","year":"2001","unstructured":"Kim YJ, Yi Y, Sapp E, Wang Y, Cuiffo B, Kegel KB, Qin ZH, Aronin N, DiFiglia M (2001) Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc Natl Acad Sci U S A 98:12784\u201312789. \n                    https:\/\/doi.org\/10.1073\/pnas.221451398","journal-title":"Proc Natl Acad Sci U S A"},{"key":"764_CR20","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.chembiol.2010.08.014","volume":"17","author":"MJ Leyva","year":"2010","unstructured":"Leyva MJ, Degiacomo F, Kaltenbach LS, Holcomb J, Zhang N, Gafni J, Park H, Lo DC, Salvesen GS, Ellerby LM et al (2010) Identification and evaluation of small molecule pan-caspase inhibitors in Huntington's disease models. Chem Biol 17:1189\u20131200. \n                    https:\/\/doi.org\/10.1016\/j.chembiol.2010.08.014","journal-title":"Chem Biol"},{"key":"764_CR21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3233\/JAD-2011-110383","volume":"26","author":"P Liu","year":"2011","unstructured":"Liu P, Kemper LJ, Wang J, Zahs KR, Ashe KH, Pasinetti GM (2011) Grape seed polyphenolic extract specifically decreases abeta*56 in the brains of Tg2576 mice. J Alzheimers Dis 26:657\u2013666. \n                    https:\/\/doi.org\/10.3233\/JAD-2011-110383","journal-title":"J Alzheimers Dis"},{"key":"764_CR22","doi-asserted-by":"publisher","first-page":"5833","DOI":"10.1016\/j.bmc.2011.08.020","volume":"19","author":"MC Maillard","year":"2011","unstructured":"Maillard MC, Brookfield FA, Courtney SM, Eustache FM, Gemkow MJ, Handel RK, Johnson LC, Johnson PD, Kerry MA, Krieger F et al (2011) Exploiting differences in caspase-2 and -3 S(2) subsites for selectivity: structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors. Bioorg Med Chem 19:5833\u20135851. \n                    https:\/\/doi.org\/10.1016\/j.bmc.2011.08.020","journal-title":"Bioorg Med Chem"},{"key":"764_CR23","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/ana.410030616","volume":"3","author":"GC McIntosh","year":"1978","unstructured":"McIntosh GC, Jameson HD, Markesbery WR (1978) Huntington disease associated with Alzheimer disease. Ann Neurol 3:545\u2013548. \n                    https:\/\/doi.org\/10.1002\/ana.410030616","journal-title":"Ann Neurol"},{"key":"764_CR24","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/nm.3951","volume":"21","author":"SW Min","year":"2015","unstructured":"Min SW, Chen X, Tracy TE, Li Y, Zhou Y, Wang C, Shirakawa K, Minami SS, Defensor E, Mok SA et al (2015) Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits. Nat Med 21:1154\u20131162. \n                    https:\/\/doi.org\/10.1038\/nm.3951","journal-title":"Nat Med"},{"key":"764_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1532-5415.1988.tb01807.x","volume":"36","author":"RJ Moss","year":"1988","unstructured":"Moss RJ, Mastri AR, Schut LJ (1988) The coexistence and differentiation of late onset Huntington's disease and Alzheimer's disease. A case report and review of the literature. J Am Geriatr Soc 36:237\u2013241","journal-title":"J Am Geriatr Soc"},{"key":"764_CR26","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1136\/jnnp.48.6.530","volume":"48","author":"RH Myers","year":"1985","unstructured":"Myers RH, Sax DS, Schoenfeld M, Bird ED, Wolf PA, Vonsattel JP, White RF, Martin JB (1985) Late onset of Huntington's disease. J Neurol Neurosurg Psychiatry 48:530\u2013534","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"764_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/mrdd.1022","volume":"7","author":"MA Nance","year":"2001","unstructured":"Nance MA, Myers RH (2001) Juvenile onset Huntington's disease\u2014clinical and research perspectives. Ment Retard Dev Disabil Res Rev 7:153\u2013157. \n                    https:\/\/doi.org\/10.1002\/mrdd.1022","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"764_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/20446","volume":"399","author":"VO Ona","year":"1999","unstructured":"Ona VO, Li M, Vonsattel JP, Andrews LJ, Khan SQ, Chung WM, Frey AS, Menon AS, Li XJ, Stieg PE et al (1999) Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 399:263\u2013267. \n                    https:\/\/doi.org\/10.1038\/20446","journal-title":"Nature"},{"key":"764_CR29","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ana.410410521","volume":"41","author":"JB Penney Jr","year":"1997","unstructured":"Penney JB Jr, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH (1997) CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol 41:689\u2013692. \n                    https:\/\/doi.org\/10.1002\/ana.410410521","journal-title":"Ann Neurol"},{"key":"764_CR30","doi-asserted-by":"crossref","unstructured":"Quarrell OWJ (2014) Juvenile Huntington's Disease. In: Bates G, Tabrizi S, Jones L, editors. Huntington's Disease. 4th ed. Oxford, New York: Oxford University Press; p. 66\u201385","DOI":"10.1093\/med\/9780199929146.003.0004"},{"key":"764_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1212\/WNL.35.2.273","volume":"35","author":"MG Reyes","year":"1985","unstructured":"Reyes MG, Gibbons S (1985) Dementia of the Alzheimer's type and Huntington's disease. Neurology 35:273\u2013277","journal-title":"Neurology"},{"key":"764_CR32","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1126\/science.1141736","volume":"316","author":"ED Roberson","year":"2007","unstructured":"Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316:750\u2013754. \n                    https:\/\/doi.org\/10.1126\/science.1141736","journal-title":"Science"},{"key":"764_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-19285-7_1","volume":"217","author":"U Rub","year":"2015","unstructured":"Rub U, Vonsattel JP, Heinsen H, Korf HW (2015) The neuropathology of Huntington s disease: classical findings, recent developments and correlation to functional neuroanatomy. Adv Anat Embryol Cell Biol 217:1\u2013146","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"764_CR34","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA et al (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14:837\u2013842. \n                    https:\/\/doi.org\/10.1038\/nm1782","journal-title":"Nat Med"},{"key":"764_CR35","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2016.03.005","volume":"90","author":"TE Tracy","year":"2016","unstructured":"Tracy TE, Sohn PD, Minami SS, Wang C, Min SW, Li Y, Zhou Y, Le D, Lo I, Ponnusamy R et al (2016) Acetylated tau obstructs KIBRA-mediated signaling in synaptic plasticity and promotes Tauopathy-related memory loss. Neuron 90:245\u2013260. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2016.03.005","journal-title":"Neuron"},{"key":"764_CR36","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/nm.4227","volume":"22","author":"CM Troy","year":"2016","unstructured":"Troy CM, Shelanski ML (2016) Caspase-2 and tau-a toxic partnership? Nat Med 22:1207\u20131208. \n                    https:\/\/doi.org\/10.1038\/nm.4227","journal-title":"Nat Med"},{"key":"764_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/B978-0-444-52014-2.00004-5","volume":"100","author":"JP Vonsattel","year":"2011","unstructured":"Vonsattel JP, Keller C, Cortes Ramirez EP (2011) Huntington's disease - neuropathology. Handb Clin Neurol 100:83\u2013100. \n                    https:\/\/doi.org\/10.1016\/B978-0-444-52014-2.00004-5","journal-title":"Handb Clin Neurol"},{"key":"764_CR38","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1093\/brain\/awv107","volume":"138","author":"R Vuono","year":"2015","unstructured":"Vuono R, Winder-Rhodes S, de Silva R, Cisbani G, Drouin-Ouellet J, Network RIotEHsD, Spillantini MG, Cicchetti F, Barker RA (2015) The role of tau in the pathological process and clinical expression of Huntington's disease. Brain 138:1907\u20131918. \n                    https:\/\/doi.org\/10.1093\/brain\/awv107","journal-title":"Brain"},{"key":"764_CR39","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007) Huntington's disease. Lancet 369:218\u2013228. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(07)60111-1","journal-title":"Lancet"},{"key":"764_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1006\/mcpr.1993.1034","volume":"7","author":"JP Warner","year":"1993","unstructured":"Warner JP, Barron LH, Brock DJ (1993) A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Mol Cell Probes 7:235\u2013239. \n                    https:\/\/doi.org\/10.1006\/mcpr.1993.1034","journal-title":"Mol Cell Probes"},{"key":"764_CR41","doi-asserted-by":"publisher","first-page":"9158","DOI":"10.1074\/jbc.273.15.9158","volume":"273","author":"CL Wellington","year":"1998","unstructured":"Wellington CL, Ellerby LM, Hackam AS, Margolis RL, Trifiro MA, Singaraja R, McCutcheon K, Salvesen GS, Propp SS, Bromm M et al (1998) Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J Biol Chem 273:9158\u20139167","journal-title":"J Biol Chem"},{"key":"764_CR42","doi-asserted-by":"publisher","first-page":"19831","DOI":"10.1074\/jbc.M001475200","volume":"275","author":"CL Wellington","year":"2000","unstructured":"Wellington CL, Singaraja R, Ellerby L, Savill J, Roy S, Leavitt B, Cattaneo E, Hackam A, Sharp A, Thornberry N et al (2000) Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J Biol Chem 275:19831\u201319838. \n                    https:\/\/doi.org\/10.1074\/jbc.M001475200","journal-title":"J Biol Chem"},{"key":"764_CR43","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1038\/nm.3700","volume":"20","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Song M, Liu X, Kang SS, Kwon IS, Duong DM, Seyfried NT, Hu WT, Liu Z, Wang JZ et al (2014) Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease. Nat Med 20:1254\u20131262. \n                    https:\/\/doi.org\/10.1038\/nm.3700","journal-title":"Nat Med"},{"key":"764_CR44","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1038\/nm.4199","volume":"22","author":"X Zhao","year":"2016","unstructured":"Zhao X, Kotilinek LA, Smith B, Hlynialuk C, Zahs K, Ramsden M, Cleary J, Ashe KH (2016) Caspase-2 cleavage of tau reversibly impairs memory. Nat Med 22:1268\u20131276. \n                    https:\/\/doi.org\/10.1038\/nm.4199","journal-title":"Nat Med"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0764-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-019-0764-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0764-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T23:14:52Z","timestamp":1595978092000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-019-0764-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,30]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["764"],"URL":"https:\/\/doi.org\/10.1186\/s40478-019-0764-9","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,30]]},"assertion":[{"value":"16 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent for clinical and neuropathologic evaluation and autopsy was obtained from all individual participants. All procedures of using de-identified human brain tissue, obtained at autopsy, were reviewed and approved by the Institutional Review Boards (IRBs) of HUB-ICO-IDIBELL Biobank (Spain), the Columbia University, the University of Miami, the Department of Veterans Affairs \u2013 Los Angeles and the University of Minnesota.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}